Search

Your search keyword '"Custidiano MDR"' showing total 1 results
Start Over Author "Custidiano MDR" Topic drug resistance, neoplasm

Refine your results

1 results on '"Custidiano MDR"'

1. Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies.

Author

Elías EE, Almejún MB, Colado A, Cordini G, Vergara-Rubio M, Podaza E, Risnik D, Cabrejo M, Fernández-Grecco H, Bezares RF, Custidiano MDR, Sánchez-Ávalos JC, Vicente Á, Garate GM, Borge M, Giordano M, and Gamberale R

Subjects
Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols pharmacology, Female, Humans, Male, Middle Aged, Protein Kinase Inhibitors pharmacology, Rituximab pharmacology, Bridged Bicyclo Compounds, Heterocyclic pharmacology, Drug Resistance, Neoplasm drug effects, Drug Resistance, Neoplasm immunology, Leukemia, Lymphocytic, Chronic, B-Cell drug therapy, Leukemia, Lymphocytic, Chronic, B-Cell enzymology, Leukemia, Lymphocytic, Chronic, B-Cell immunology, Leukemia, Lymphocytic, Chronic, B-Cell pathology, Lymphocyte Activation drug effects, Neoplasm Proteins antagonists & inhibitors, Neoplasm Proteins immunology, Neoplasm Proteins metabolism, Sulfonamides pharmacology, Syk Kinase antagonists & inhibitors, Syk Kinase immunology, Syk Kinase metabolism, T-Lymphocytes immunology, T-Lymphocytes pathology
Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results